ICD Pharma

Cannabinoid Products

Health Tech & Life Sciences
Non Active, Jan 2024 ceased to operate
Pre-Funding Karmei Yosef Founded 2017
LinkedIn
Total raised
Stage
Pre-Funding
Founded
2017
Headcount
1-10
HQ
Karmei Yosef
Sector
Health Tech & Life Sciences

About

ICD Pharma is a clinical-stage pharmaceutical company developing cannabis-based therapies for use as medical cannabis products and for longer-term clinical development of FDA-approved drugs. The company's pipeline includes oral and topical cannabinoid-based products based on a portfolio of proprietary pharmaceutical delivery technologies.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the current operational status of ICD Pharma?
ICD Pharma is currently inactive, having ceased operations in January 2024.
When was ICD Pharma founded?
ICD Pharma was founded in April 2017.
What is ICD Pharma's primary focus in product development?
ICD Pharma is a clinical-stage pharmaceutical company focused on developing cannabis-based therapies, including oral and topical cannabinoid products, for medical use and potential FDA-approved drugs.
Where is ICD Pharma headquartered?
ICD Pharma's headquarters are located in Karmei Yosef, Israel.
What is ICD Pharma's current funding stage?
ICD Pharma is currently in the Pre-Funding stage.
How many founders does ICD Pharma have?
ICD Pharma has three founders: Eran Tor, Dr. Doron Friedman, and Eran Perry.
What type of intellectual property does ICD Pharma possess?
ICD Pharma holds at least one patent related to its proprietary pharmaceutical delivery technologies.
What is the estimated employee count for ICD Pharma?
ICD Pharma has an estimated employee count of 1-10 individuals.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Highlights

1 Patents

Tags

cannabisbiological-therapynatural-active-ingredientspharmaceuticalschronic-patientspatients